Biofilms make ventilator-associated pneumonia (VAP) even harder to treat, and adding enzymes to antimicrobial treatment could be a solution, according to researchers at the University of Warwick.
VAP is a common infection in patients using ventilators. Up to 40% of ventilated patients in intensive care wards will develop VAP, with 10% of those patients not surviving.
In a recent study, researchers in the laboratory recreated hospital conditions to improve understanding of the infection